Article information
Full text is only available in PDF
Bibliografía
[1.]
J. Ena, V. Valls, C. Pérez de Oteyza, R. Enríquez de Salamanca.
Utilidad y limitaciones de la adenosina desaminasa en el diagnóstico de la pleuresía tuberculosa. Estudio metaanalítico.
Med Clin (Barc), 95 (1990), pp. 333-335
[2.]
M. Marel, B. Stastny, L. Melinova, E. Svandova, R.W. Light.
Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.
Chest, 107 (1995), pp. 1598-1603
[3.]
U.B. Prakash, H.M. Reiman.
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusio: analysis of 414 cases.
Mayo Clin Proc, 60 (1985), pp. 158-164
[4.]
R. Menzies, M. Charbonneau.
Thoracoscopy for the diagnosis of pleural disease.
Ann Intern Med, 114 (1991), pp. 271-276
[5.]
A. Ruibal, J. Genolla.
Marcadores tumorales y derrames pleurales.
Med Clin (Barc), 86 (1986), pp. 457-460
[6.]
B. Bergman, F.T. Brezicka, C.P. Engstrom, S. Larsson.
Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
Eur J Cancer, 29 (1993), pp. 198-202
[7.]
S. Romero, C. Fernández, J.M. Arriero, A. Espasa, A. Candela, C. Martin, et al.
CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
Eur Respir J, 9 (1996), pp. 17-23
[8.]
J. Lindgren, P. Kuusela, P.E. Hellstrom, T. Pettersson, M. Klockars.
The ovarian cancer associated antigen CA 125 in patients with pleural effusions.
Eur J Cancer Clin Oncol, 24 (1988), pp. 737-739
[9.]
J. Ferrer, M.A. Villarino, G. Encabo, E. Felip, B. Bermejo, S. Vila, et al.
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
Cancer, 86 (1999), pp. 1488-1495
[10.]
P. Gold, S.O. Freedman.
Specific carcinoembryonic antigens of the human digestive system.
J Exp Med, 122 (1965), pp. 467-481
[11.]
D.N. Carney, P.J. Marangos, D.C. Ihde, P.A. Bunn Jr., M.H. Cohen, J.D. Minna, et al.
Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Lancet, 1 (1982), pp. 583-585
[12.]
M.S. Schilthuis, J.G. Aalders, J. Bouma, H. Kooi, G.J. Fleuren, P.H. Willemse, et al.
S erum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
Br J Obstet Gynaecol, 94 (1987), pp. 202-207
[13.]
R. Colomer, L.A. Solé, M. Navarro, G. Encabo, A. Ruibal.
Salvador Ll. Ca 15.3: early results of a new breast cancer marker.
Anticancer Res, 6 (1986), pp. 683-684
[14.]
J.L. Magnani, Z. Steplewski, H. Koprowski, V. Ginsburg.
Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as mucin.
Cancer Res, 43 (1983), pp. 5489-5492
[15.]
P. Ferroni, C. Szpak, J.W. Greiner, J.F. Simpson, F. Guadagni, W.W. Johnston, et al.
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers.
Int J Cancer, 46 (1990), pp. 445-451
[16.]
P. Stieber, A. Zimmermann, J. Reinmiedl, C. Muller, H. Hoffmann, H. Dienemann.
CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC).
Anticancer Res, 19 (1999), pp. 2665-2668
[17.]
J. Mezger, W. Permanetter, A.L. Gerbes, W. Wilmanns, R. Lamerz.
Tumour associated antigens in diagnosis of serous effusions.
J Clin Pathol, 41 (1988), pp. 633-643
[18.]
M. Toumbis, K. Chondros, A.S. Ferderigos, M. Daganou, A. Dema, A. Dalamaga, et al.
Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
Anticancer Res, 12 (1992), pp. 1267-1270
[19.]
A. Ammon, H. Eiffert, S. Reil, J.H. Beyer, M. Droese, W. Hiddemann.
Tumor-associated antigens in effusions of malignant and benign origin.
Clin Investig, 71 (1993), pp. 437-444
[20.]
M. Klockars, J. Lindgren, T. Pettersson, P.E. Hellstrom, A. Norhagen.
Carcinoembryonic antigen in pleural effusions [carta].
Lancet, 2 (1978), pp. 1057-1058
[21.]
R.A. Rittgers, M.S. Loewenstein, A.E. Feinerman, H.Z. Kupchik, B.R. Marcel, R.S. Koff, et al.
Carcinoembryonic antigen levels in benign and malignant pleural effusions.
Ann Intern Med, 88 (1978), pp. 631-634
[22.]
A.O. Vladutiu, F.W. Brason, R.H. Adler.
Differential diagnosis of pleural effusions: clinical usefulness of cell marker quantitation.
Chest, 79 (1981), pp. 297-301
[23.]
M. Toumbis, A. Rasidakis, E. Passalidou, J. Kalomenidis, M. Alchanatis, D. Orphanidou, et al.
Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Anticancer Res, 16 (1996), pp. 2101-2104
[24.]
H. Satoh, M. Sumi, H. Yagyu, H. Ishikawa, T. Suyama, T. Naitoh, et al.
Clinical evaluation of CYFRA 21-1 in malignant pleural fluids.
Oncology, 52 (1995), pp. 211-214
[25.]
A.M. Zeillemaker, H.A. Verbrugh, A.A. Hoynck van Papemndrecht, P. Leguit.
CA 125 secretion by peritoneal mesothelial cells.
J Clin Pathol, 47 (1994), pp. 263-265
[26.]
J.P. Ouhayoun, J.C. Goffaux, M.H. Sawaf, A.H. Shabana, C. Collin, N. Forest.
Changes in cytokeratin expression in gingiva durimng inflammation.
J Periodontal Res, 25 (1990), pp. 283-292
[27.]
B. Faravelli, M. Nosenzo, A. Razzetti, D. Barone, E. D’Amore, R. Bandelloni, et al.
The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies.
Eur J Cancer Clin Oncol, 21 (1985), pp. 1083-1087
[28.]
O. Menard, B. Dousset, C. Jacob, Y. Martinet.
Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.
Eur J Cancer, 29 (1993), pp. 1806-1809
[29.]
G. Salama, M. Miedouge, P. Rouzaud, M.A. Mauduyt, M.C. Pujazon, C. Vincent, et al.
Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Br J Cancer, 61 (1998), pp. 298-302
[30.]
S. Tamura, T. Nishigaki, Y. Moriwaki, H. Fujioka, T. Nakano, J. Fuji, et al.
Tumor markers in pleural effusion diagnosis.
Cancer, 61 (1988), pp. 298-302
[31.]
K. Shimokata, Y. Totani, K. Nakanishi, M. Yamamoto, Y. Hasegawa, H. Kawatsu, et al.
Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antiboides (115D8 and DF3) in exudative pleural effusions.
Eur Respir J, 1 (1988), pp. 341-344
[32.]
K. Shimokata, Y. Niwa, M. Yamamoto, H. Sasou, M. Morishita.
Pleural fluid neuronspecific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Chest, 95 (1989), pp. 602-603
[33.]
B. Chernow, S.A. Sahn.
Carcinomatous involvement of the pleura: an analysis of 96 patients.
Am J Med, 63 (1977), pp. 695-702
[34.]
V. Villena, A. López Encuentra, J. Echave Sustaeta, P. Martin Escribano, B. Ortuno de Solo, J. Estenoz Alfaro.
Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Cancer, 78 (1996), pp. 736-740
[35.]
J. Mezger, A. Calavrezos, P. Drings, U. Gatzemeier, et al.
Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.
Lung, 172 (1994), pp. 183-184
[36.]
J.S. Ferrer, X.G. Muñoz, R.M. Orriols, R.W. Light, F.B. Morell.
Evolution of idiopathic pleural effusion: a prospective, long-term follow- up study.
Chest, 109 (1996), pp. 1508-1513
[37.]
D. Weissberg, M. Kaufmann.
Diagnostic and therapeutic pleuroscopy Experience with 127 patients.
Chest, 78 (1980), pp. 732-735
Copyright © 2000. Sociedad Española de Neumología y Cirugía Torácica
